QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) A correction has been published Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (136) Citing Articles via Google Scholar Google Scholar Articles by Perez, R. G. Articles by Zigmond, M. J. Search for Related Content PubMed PubMed Citation Articles by Perez, R. G. Articles by Zigmond, M. J.

 Previous Article  |  Next Article 

The Journal of Neuroscience, April 15, 2002, 22(8):3090-3099

A Role for -Synuclein in the Regulation of Dopamine Biosynthesis

Ruth G. Perez¹, Jack C. Waymire³, Eva Lin¹, Jen J. Liu¹, Fengli Guo², and Michael J. Zigmond¹

¹ Department of Neurology and ² Center for Biological Imaging, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, and ³ Department of Neurobiology and Anatomy, University of Texas Medical School, Houston, Texas 77030

The -synuclein gene is implicated in the pathogenesis of Parkinson's disease. Although -synuclein function is uncertain, the protein has homology to the chaperone molecule 14-3-3. In addition, -synuclein can bind to 14-3-3, and both -synuclein and 14-3-3 bind to many of the same proteins. Because 14-3-3 binds to and activates tyrosine hydroxylase, the rate-limiting enzyme in dopamine (DA) biosynthesis, we explored whether -synuclein also bound to tyrosine hydroxylase and influenced its activity. Immunoprecipitation revealed an interaction between -synuclein and tyrosine hydroxylase in brain homogenates and MN9D dopaminergic cells. Colocalization of -synuclein with tyrosine hydroxylase was confirmed by immunoelectron microscopy. To explore the consequences of the interaction, we measured the effect of recombinant -synuclein on tyrosine hydroxylase activity in a cell-free system and observed a dose-dependent inhibition of tyrosine hydroxylase by -synuclein. To measure the impact of -synuclein on tyrosine hydroxylase in dopaminergic cells, we stably transfected MN9D cells with wild-type or A53T mutant -synuclein. Overexpression of wild-type or A53T mutant -synuclein did not significantly alter tyrosine hydroxylase protein levels in our stably transfected cells. However, overexpressing cell lines had significantly reduced tyrosine hydroxylase activity and a corresponding reduction in dopamine synthesis. The reduction in cellular dopamine levels was not caused by increased dopamine catabolism or dopamine efflux. These data suggest that -synuclein plays a role in the regulation of dopamine biosynthesis, acting to reduce the activity of tyrosine hydroxylase. If so, a loss of soluble -synuclein, by reduced expression or aggregation, could increase dopamine synthesis with an accompanying increase in reactive dopamine metabolites.

Key words: 14-3-3; MN9D; Parkinson's disease; phosphorylation; rat brain; tyrosine hydroxylase

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/2283090-10$05.00/0

This article has been cited by other articles:

				S. Orimo, T. Uchihara, A. Nakamura, F. Mori, A. Kakita, K. Wakabayashi, and H. Takahashi Axonal {alpha}-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease Brain, March 1, 2008; 131(3): 642 - 650. [Abstract] [Full Text] [PDF]

				M. Cs. Horvath, G. G. Kovacs, V. Kovari, K. Majtenyi, Y. L. Hurd, and E. Keller Heroin Abuse Is Characterized by Discrete Mesolimbic Dopamine and Opioid Abnormalities and Exaggerated Nuclear Receptor-Related 1 Transcriptional Decline with Age J. Neurosci., December 5, 2007; 27(49): 13371 - 13375. [Abstract] [Full Text] [PDF]

				M. Periquet, T. Fulga, L. Myllykangas, M. G. Schlossmacher, and M. B. Feany Aggregated {alpha}-Synuclein Mediates Dopaminergic Neurotoxicity In Vivo J. Neurosci., March 21, 2007; 27(12): 3338 - 3346. [Abstract] [Full Text] [PDF]

				K. E. Larsen, Y. Schmitz, M. D. Troyer, E. Mosharov, P. Dietrich, A. Z. Quazi, M. Savalle, V. Nemani, F. A. Chaudhry, R. H. Edwards, et al. {alpha}-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis. J. Neurosci., November 15, 2006; 26(46): 11915 - 11922. [Abstract] [Full Text] [PDF]

				E. Kontopoulos, J. D. Parvin, and M. B. Feany {alpha}-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity Hum. Mol. Genet., October 15, 2006; 15(20): 3012 - 3023. [Abstract] [Full Text] [PDF]

				F. Urano, N. Hayashi, F. Arisaka, H. Kurita, S. Murata, and H. Ichinose Molecular mechanism for pterin-mediated inactivation of tyrosine hydroxylase: formation of insoluble aggregates of tyrosine hydroxylase. J. Biochem., April 1, 2006; 139(4): 625 - 635. [Abstract] [Full Text] [PDF]

				C.-s. Liang, W. Mao, C. Iwai, S. Fukuoka, and S. Y. Stevens Cardiac sympathetic neuroprotective effect of desipramine in tachycardia-induced cardiomyopathy Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H995 - H1003. [Abstract] [Full Text] [PDF]

				T. Kuwahara, A. Koyama, K. Gengyo-Ando, M. Masuda, H. Kowa, M. Tsunoda, S. Mitani, and T. Iwatsubo Familial Parkinson Mutant {alpha}-Synuclein Causes Dopamine Neuron Dysfunction in Transgenic Caenorhabditis elegans J. Biol. Chem., January 6, 2006; 281(1): 334 - 340. [Abstract] [Full Text] [PDF]

				R. Ved, S. Saha, B. Westlund, C. Perier, L. Burnam, A. Sluder, M. Hoener, C. M. P. Rodrigues, A. Alfonso, C. Steer, et al. Similar Patterns of Mitochondrial Vulnerability and Rescue Induced by Genetic Modification of {alpha}-Synuclein, Parkin, and DJ-1 in Caenorhabditis elegans J. Biol. Chem., December 30, 2005; 280(52): 42655 - 42668. [Abstract] [Full Text] [PDF]

				M. A. Utton, W. J. Noble, J. E. Hill, B. H. Anderton, and D. P. Hanger Molecular motors implicated in the axonal transport of tau and {alpha}-synuclein J. Cell Sci., October 15, 2005; 118(20): 4645 - 4654. [Abstract] [Full Text] [PDF]

				X. M. Peng, R. Tehranian, P. Dietrich, L. Stefanis, and R. G. Perez {alpha}-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells J. Cell Sci., August 1, 2005; 118(15): 3523 - 3530. [Abstract] [Full Text] [PDF]

				S. Cao, C. C. Gelwix, K. A. Caldwell, and G. A. Caldwell Torsin-Mediated Protection from Cellular Stress in the Dopaminergic Neurons of Caenorhabditis elegans J. Neurosci., April 13, 2005; 25(15): 3801 - 3812. [Abstract] [Full Text] [PDF]

				D. Bonsch, T. Lederer, U. Reulbach, T. Hothorn, J. Kornhuber, and S. Bleich Joint analysis of the NACP-REP1 marker within the alpha synuclein gene concludes association with alcohol dependence Hum. Mol. Genet., April 1, 2005; 14(7): 967 - 971. [Abstract] [Full Text] [PDF]

				R. Bussell Jr., T. F. Ramlall, and D. Eliezer Helix periodicity, topology, and dynamics of membrane-associated {alpha}-Synuclein Protein Sci., April 1, 2005; 14(4): 862 - 872. [Abstract] [Full Text] [PDF]

				G.-R. Kweon, J. D. Marks, R. Krencik, E. H. Leung, P. T. Schumacker, K. Hyland, and U. J. Kang Distinct Mechanisms of Neurodegeneration Induced by Chronic Complex I Inhibition in Dopaminergic and Non-dopaminergic Cells J. Biol. Chem., December 10, 2004; 279(50): 51783 - 51792. [Abstract] [Full Text] [PDF]

				R. Hodara, E. H. Norris, B. I. Giasson, A. J. Mishizen-Eberz, D. R. Lynch, V. M.-Y. Lee, and H. Ischiropoulos Functional Consequences of {alpha}-Synuclein Tyrosine Nitration: DIMINISHED BINDING TO LIPID VESICLES AND INCREASED FIBRIL FORMATION J. Biol. Chem., November 12, 2004; 279(46): 47746 - 47753. [Abstract] [Full Text] [PDF]

				S. M. Fleming, J. Salcedo, P.-O. Fernagut, E. Rockenstein, E. Masliah, M. S. Levine, and M.-F. Chesselet Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human {alpha}-Synuclein J. Neurosci., October 20, 2004; 24(42): 9434 - 9440. [Abstract] [Full Text] [PDF]

				W. Li, C. Lesuisse, Y. Xu, J. C. Troncoso, D. L. Price, and M. K. Lee Stabilization of {alpha}-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation J. Neurosci., August 18, 2004; 24(33): 7400 - 7409. [Abstract] [Full Text] [PDF]

				B. Nuscher, F. Kamp, T. Mehnert, S. Odoy, C. Haass, P. J. Kahle, and K. Beyer {alpha}-Synuclein Has a High Affinity for Packing Defects in a Bilayer Membrane: A THERMODYNAMICS STUDY J. Biol. Chem., May 21, 2004; 279(21): 21966 - 21975. [Abstract] [Full Text] [PDF]

				M. K. Dougherty and D. K. Morrison Unlocking the code of 14-3-3 J. Cell Sci., April 15, 2004; 117(10): 1875 - 1884. [Abstract] [Full Text] [PDF]

				A. RECCHIA, P. DEBETTO, A. NEGRO, D. GUIDOLIN, S. D. SKAPER, and P. GIUSTI {alpha}-Synuclein and Parkinson's disease FASEB J, April 1, 2004; 18(6): 617 - 626. [Abstract] [Full Text] [PDF]

				A. SIDHU, C. WERSINGER, and P. VERNIER Does {alpha}-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J, April 1, 2004; 18(6): 637 - 647. [Abstract] [Full Text] [PDF]

				A. J. Baucum II, K. S. Rau, E. L. Riddle, G. R. Hanson, and A. E. Fleckenstein Methamphetamine Increases Dopamine Transporter Higher Molecular Weight Complex Formation via a Dopamine- and Hyperthermia-Associated Mechanism J. Neurosci., March 31, 2004; 24(13): 3436 - 3443. [Abstract] [Full Text] [PDF]

				W. Zhou and C. R. Freed Tyrosine-to-Cysteine Modification of Human {alpha}-Synuclein Enhances Protein Aggregation and Cellular Toxicity J. Biol. Chem., March 12, 2004; 279(11): 10128 - 10135. [Abstract] [Full Text] [PDF]

				A. R. Saha, J. Hill, M. A. Utton, A. A. Asuni, S. Ackerley, A. J. Grierson, C. C. Miller, A. M. Davies, V. L. Buchman, B. H. Anderton, et al. Parkinson's disease {alpha}-synuclein mutations exhibit defective axonal transport in cultured neurons J. Cell Sci., March 1, 2004; 117(7): 1017 - 1024. [Abstract] [Full Text] [PDF]

				M. J. Baptista, M. R. Cookson, and D. W. Miller Parkin and {alpha}-Synuclein: Opponent Actions in The Pathogenesis of Parkinson'S Disease Neuroscientist, February 1, 2004; 10(1): 63 - 72. [Abstract] [PDF]

				Y. Nagano, H. Yamashita, T. Takahashi, S. Kishida, T. Nakamura, E. Iseki, N. Hattori, Y. Mizuno, A. Kikuchi, and M. Matsumoto Siah-1 Facilitates Ubiquitination and Degradation of Synphilin-1 J. Biol. Chem., December 19, 2003; 278(51): 51504 - 51514. [Abstract] [Full Text] [PDF]

				T. Liang, J. Spence, L. Liu, W. N. Strother, H. W. Chang, J. A. Ellison, L. Lumeng, T.-K. Li, T. Foroud, and L. G. Carr alpha -Synuclein maps to a quantitative trait locus for alcohol preference and is differentially expressed in alcohol-preferring and -nonpreferring rats PNAS, April 15, 2003; 100(8): 4690 - 4695. [Abstract] [Full Text] [PDF]

				K. Steece-Collier, E. Maries, and J. H. Kordower Etiology of Parkinson's disease: Genetics and environment revisited PNAS, October 29, 2002; 99(22): 13972 - 13974. [Full Text] [PDF]

				J. Lotharius and P. Brundin Impaired dopamine storage resulting from {alpha}-synuclein mutations may contribute to the pathogenesis of Parkinson's disease Hum. Mol. Genet., October 1, 2002; 11(20): 2395 - 2407. [Abstract] [Full Text] [PDF]

				S. M. Park, H. Y. Jung, T. D. Kim, J. H. Park, C.-H. Yang, and J. Kim Distinct Roles of the N-terminal-binding Domain and the C-terminal-solubilizing Domain of alpha -Synuclein, a Molecular Chaperone J. Biol. Chem., August 2, 2002; 277(32): 28512 - 28520. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help